ID   NOS2CR
AC   CVCL_RN29
DR   Wikidata; Q54930918
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T747 ! NOS2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
RX   PubMed=8978593; DOI=10.1159/000227661;
RA   Wakahara, Yasunori
RA   Nawa, Akihiro
RA   Okamoto, Tomomitsu
RA   Hayakawa, Akemi
RA   Kikkawa, Fumitaka
RA   Suganama, Nobuhiko
RA   Wakahara, Fumiyo
RA   Tomoda, Yutaka
RT   "Combination effect of anti-Fas antibody and chemotherapeutic drugs in
RT   ovarian cancer cells in vitro.";
RL   Oncology 54:48-54(1997).
//